Permanent atrial pacing lead implant route after Fontan operation
- PMID: 19545341
- PMCID: PMC4266486
- DOI: 10.1111/j.1540-8159.2009.02365.x
Permanent atrial pacing lead implant route after Fontan operation
Abstract
Background: Atrial pacing is indicated for sinus node dysfunction (SND) after Fontan surgery; preferred lead implantation technique is debated. We compare outcomes of transvenous (TV) and epicardial (Epi) atrial lead implants in this population.
Methods: Retrospective review of Fontan patients undergoing atrial lead implant between 1992 and 2007. Demographics, lead performance data, and outcomes were analyzed.
Results: 78 patients had 90 leads implanted: 25 via TV route and 65 via Epi route. Median follow-up was 1.6 years (TV) and 3.6 years (Epi). TV leads were implanted in older patients (23.1 vs 9.3 years, P < 0.001) and at longer intervals after Fontan (15.2 vs 4.9 years, P < 0.001). Pacing indication for most TV leads was SND, while Epi leads were also indicated for atrioventricular block. Acute complication rates were similar (8% TV vs 19% Epi, P = 0.23), but median hospital stay was shorter for TV (2 vs 5 days, P = 0.03). Thrombus was observed in five patients (two in TV; three in Epi), but no thromboembolic events were observed. Mean lead survival was similar (TV 9.9 vs Epi 7.8 years, P = NS). Energy threshold was lower at implant for TV leads (0.9 vs 2.2 microJ, P = 0.049), but similar at follow-up (1.2 vs 2.6 microJ, P = 0.35). Atrial sensing was unchanged over time for TV (2.2 to 2.1 mV, P = NS), but decreased for Epi (3.3 to 2.5 mV, P = 0.02).
Conclusions: Compared to epicardial leads, transvenous atrial pacing leads may be placed in Fontan patients with lower procedural morbidity and equivalent expectation of lead performance and longevity.
Figures
Similar articles
-
Cardiac pacing in paediatric patients with congenital heart defects: transvenous or epicardial?Europace. 2013 Sep;15(9):1280-6. doi: 10.1093/europace/eut029. Epub 2013 Feb 24. Europace. 2013. PMID: 23439868
-
Endocardial atrial pacing lead implantation and midterm follow-up in young patients with sinus node dysfunction after the fontan procedure.Pacing Clin Electrophysiol. 2004 Jul;27(7):949-54. doi: 10.1111/j.1540-8159.2004.00564.x. Pacing Clin Electrophysiol. 2004. PMID: 15271015
-
Long-term follow-up shows excellent transmural atrial lead performance in patients with complex congenital heart disease.Circ Arrhythm Electrophysiol. 2014 Aug;7(4):652-7. doi: 10.1161/CIRCEP.113.001321. Epub 2014 Jun 6. Circ Arrhythm Electrophysiol. 2014. PMID: 24907290
-
Efficacy of prophylactic epicardial pacing leads in children and young adults.Ann Thorac Surg. 2004 Jul;78(1):197-202; discussion 202-3. doi: 10.1016/j.athoracsur.2004.02.008. Ann Thorac Surg. 2004. PMID: 15223427 Review.
-
Cardiac pacing strategies and post-implantation risk of atrial fibrillation and heart failure events in sinus node dysfunction patients: a collaborative analysis of over 6000 patients.Clin Res Cardiol. 2016 Aug;105(8):687-698. doi: 10.1007/s00392-016-0973-1. Epub 2016 Feb 25. Clin Res Cardiol. 2016. PMID: 26913516 Review.
Cited by
-
Transvenous approach to pacemaker lead implantation for sinus node dysfunction after extracardiac lateral tunnel Fontan conduit placement.HeartRhythm Case Rep. 2016 Sep 14;2(6):495-498. doi: 10.1016/j.hrcr.2016.07.006. eCollection 2016 Nov. HeartRhythm Case Rep. 2016. PMID: 28491745 Free PMC article. No abstract available.
-
Use of an electroanatomic mapping system with high-density multipolar mapping catheters to guide transvenous atrial pacing lead implantation in a Fontan patient.HeartRhythm Case Rep. 2023 Oct 31;10(1):49-52. doi: 10.1016/j.hrcr.2023.10.020. eCollection 2024 Jan. HeartRhythm Case Rep. 2023. PMID: 38264119 Free PMC article. No abstract available.
-
Management of late arrhythmias in adults with repaired congenital heart disease.Curr Treat Options Cardiovasc Med. 2013 Oct;15(5):615-31. doi: 10.1007/s11936-013-0254-5. Curr Treat Options Cardiovasc Med. 2013. PMID: 23775510
-
Pacing in Patients with Congenital Heart Disease: When Is It Helpful and When Is It Harmful?Curr Cardiol Rep. 2020 Jan 16;22(1):5. doi: 10.1007/s11886-020-1253-2. Curr Cardiol Rep. 2020. PMID: 31950297 Review.
-
Transvenous Versus Epicardial Pacing in Fontan Patients.Pediatr Cardiol. 2018 Oct;39(7):1484-1488. doi: 10.1007/s00246-018-1920-x. Epub 2018 Jun 11. Pediatr Cardiol. 2018. PMID: 29948024
References
-
- Cohen MI, Wernovsky G, Vetter VL, Wieand TS, Gaynor JW, Jacobs ML, Spray TL, et al. Sinus node dysfunction after a systematically staged Fontan procedure. Circulation. 1998;98:352II–358II. - PubMed
-
- Cohen MI, Bridges ND, Gaynor JW, Hoffman TM, Wernovsky G, Vetter VL, Spray TL, et al. Modifications to the cavopulmonary anastomosis do not eliminate early sinus node dysfunction. J Thorac Cardiovasc Surg. 2000;120:891–901. - PubMed
-
- Bae E-J, Lee J-Y, Noh C-I, Kim W-H, Kim Y-J. Sinus node dysfunction after Fontan modifications influence of surgical method. Int J Cardiol. 2003;88:285–291. - PubMed
-
- Driscoll DJ, Offord KP, Feldt RH, Schaff HV, Puga FJ, Danielson GK. Five-to fifteen-year follow-up after Fontan operation. Circulation. 1992;85:469–496. - PubMed
-
- Petko M, Myung RJ, Wernovsky G, Cohen MI, Rychik J, Nicolson SC, Spray TL, et al. Surgical reinterventions following the Fontan procedure. Eur J Cardiothorac Surg. 2003;24:255–259. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous